Updates from the CLL14 and CLL2-GiVe trials on CLL
Follow-up results of looking at treatment with ibrutinib on CLL patient survival and adverse events
Can concepts from CLL be applied to other liquid and solid tumors?
Developing safe and effective agents for the treatment of CLL
Exciting insights into the role of ROR1 in CLL